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Trypanosoma brucei-infected rats were treated with natural honey and honey-supplemented diet at 
three days before infection (prophylaxis), early and late stages of infection. Proximate percentage 
composition of the honey was 71.19±0.90% carbohydrate, 3.28±0.05% protein and 10.68±0.27% lipid 
among others. Prophylactic treatment with natural honey extended the lifespan of infected rats by 13 
extra days from a control of 12 days post infection while early and late stage treatments extended the 
lifespan by 10 and 5 days, respectively. Prophylactic feeding with honey-supplemented diet extended 
the lifespan by 6 extra days while early and late stage feeding extended it for 5 and 3 days, respectively. 
A specific pattern could not be established for alkaline phosphatase (ALP), glutamate oxaloacetate 
transaminase (GOT) and glutamate pyruvate transaminase (GPT) enzyme activities in the liver and 
serum. We conclude that honey even as part of a regular diet could be a useful, cheap and readily 
presentable agent in the management of African sleeping sickness for residents of disease endemic 
areas.  
 





Trypanosomosis, caused by African trypanosomes 
continues to be a public threat in tropical Africa (Abenga 
and Lawal, 2005; Chretien and Smoak, 2005). Drug 
regiments are toxic and cumbersome in addition to being 
expensive (Kioy and Mattock, 2005; Moore, 2005). The 
onus is to continue to seek inexpensive and less 
cumbersome approaches to the management and 
treatment of the disease (Jannin and Cattand, 2004; 
Moore, 2005). 
Honey is a natural product that is widely available in 
different parts of the world  (Terrab et al., 2003; Yao et 
al., 2003; Bonvehí et al., 2004; Sanz et al., 2004; 
Malacalza et al., 2005) and is readily obtained from 
natural or cultured bee colonies. It has been reported as 
having antimicrobial properties (Al-Waili and Saloom, 
1999; Adebolu, 2005) as well as therapeutic effects on 
internal  and  external ailments (Okeniyi, 2005; Orsolic et  
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al., 2005). Identification of natural products active against 
African trypanosomosis has been described as a step 
towards treatment and control of the disease (Hoet et al., 
2004). We have earlier suggested that honey could be a 
potential agent in the management of African sleeping 
sickness (Ekanem and Yusuf, 2005). In this report, using 
infected but untreated rats as control, we confirm that 
honey could be a useful agent in the management of 
African trypanosomosis. We assess the possibility of 
making it a part of the diet for the infected individuals and 
also see how this affects the levels of some enzyme 
activities in the host. 
 
 




Honey was obtained from Faculty of Agriculture, University of Ilorin, 
Nigeria. Rats were obtained from the Animal Holdings of the 
Department of Biochemistry, University of Ilorin, Nigeria.  




Table 1. Composition of the diet used to maintain T. brucei-
infected rats (g/Kg). 
 
Feed component Weight 
Corn starch 516 
Soybean 250 
Oil 40 
Cellulose (rice husk) 40 
*Vitamin/Mineral mix 50 
DL-methionine 4 
Honey 100 
                                               
*Vitamin/Mineral mix (per Kg of diet): Thiamin hydrochloride, 6 mg; 
Pyridoxin hydrochloride, 7 mg; nicotinic acid, 30 mg; folic acid, 2 mg; 
calcium pantothenate,16 mg; biotin, 0.2 mg; cyanocobalamin, 0.01 mg; 
retinal palmitate, 4000 IU; cholecalciferol, 1000 IU; tocopherol acetate 
50 IU; menadione 0.05 mg; choline chloride, 2 g; CoCl2.6H2O, 0.001 g; 
CuSO4.5H2O, 0.079 g; MnSO4, 0.178 g; KI, 0.032 g; KH2PO4, 5.559 g; 
CaSO4, 5.25 g; NaCl, 5.573 g; ZnCO3 , 1.6 g; FeSO4.7H2O, 1.078 g; 




Trypanosoma brucei brucei was collected from Veterinary and 
Livestock Studies Department, Nigeria Institute for Trypanosomiasis  
Research, Vom, near Jos, Nigeria. Glutamate pyruvate 
transaminase (GPT) and glutamate oxaloacetate transaminase 
(GOT) assay kits were products of Randox Laboratories Customer 
Technical Support, Northern Ireland. Alkaline Phosphatase (ALP) 
assay kit was a product of Teco Diagnostics, 1268 N. Lakeview 
Avenue, Anaehim, CA 92 807. 
 
 
Inoculation of rats  
 
Parasite infested blood was obtained from the tail of infected rats at 
high parasitemia and used to maintain parasite suspension in  
0.90% saline solution which was inoculated into the peritoneal 
cavity of uninfected rat weighing approximately 250 g. The 
suspension contained 3 or 4 trypanosomes per view at x100 





Proximate analysis was carried out as described in AOAC (1999) to 
estimate moisture, crude protein, crude fibre, fat and ash content. 
The carbohydrate content was obtained by subtracting the sum of 





Feed was formulated with the different classes of food: corn starch 
was used as carbohydrate, dried milled soybean was used as 
protein, pure soybean oil was used as a source of lipid and dried 
rice husk was used as fibre. Other ingredients of the feed include 
DL-methionine and vitamin/mineral mix. Honey was added as 
supplement. These are shown in Table 1. Commercial feed used as 
diet for the control rats was a product of Bendel Feeds and Flour 
Mills Ltd, Ewu, Edo State, Nigeria.   
 
 
Tissue collection and preparation 
 
Rats were anaesthetized using cotton wool soaked in chloroform. 





and syringe from where they were transferred into centrifuge tubes. 
The blood was allowed to clot for 10 min at room temperature and 
then centrifuged using laboratory centrifuge (SM800B, Surgified 
Medicals, England) at 3000 rpm for 5 min. The serum was then 
separated with a clean Pasteur pipette and stored frozen until 
required for use (Ogbu and Okechukwu, 2001). The liver was 
excised, cleansed of blood and superficial connective tissues and 
transferred into ice cold 0.25 M sucrose solution. The liver was cut 
with a sterile blade and homogenized in an ice cold 0.25 M sucrose 
solution (1:5 w/v) using Teflon homogenizer. Maximal release of 
enzyme activities was ensured by freezing the homogenate (Ngaha 





ALP was assayed using the phenolphthalein monophosphate 
method of Klein et al (1960) as revised by Babson et al (1966). 
GOT and GPT were assayed following the method of Reitman and 
Frankel (1957). The protein content was determined using biuret 
reagent as reported by Gornall et al. (1949). Measurement of the 
activities was done using spectronic 21 digital spectrophotometer 
(Bausch and Lomb Rochester, New York). 
 
 
Statistical analysis    
 
Data are presented as mean of four replicates ± standard error of 
mean (SEM). Analysis of variance was carried out and 
complemented with student’s t-test. Level of statistical significance 





In the first experiment, infected rats of four in each group were 
inoculated intraperitoneally with honey at 100 mg/kg body weight 72 
h before infection for prophylactic assessment, on the first day of 
sighting parasite in the blood (3 to 4 days post infection) for early 
stage treatment and on day 9 for late stage treatment. In the 
second experiment, honey supplemented diet were fed to rats for 
prophylactic, early and late stage treatments. Serum and liver 
activities of ALP, GPT and GOT were also determined in the rats at 






Proximate composition of honey 
 
The proximate composition of honey used for this work 
(Table 2) shows that carbohydrate forms 71.19 ± 0.90% 
of it. Lipid and protein among other contents were 10.61 





Figure 1 shows the result of infected rats administered 
with honey intraperitoneally at 100 mg/Kg body weight for 
prophylactic, early and late stage treatments. Prophylac-
tic treatment extended the lifespan by 13 days while early 
and late stage treatments extended the lifespan for 10 
and 5 days, respectively. The progress of the infection in 






         Table 2. Proximate composition of honey used in this study. 
 
Food Class Percentage (%) 
Carbohydrate 71.19 ± 0.90 
Protein 3.28 ± 0.05 
Lipid 10.68 ± 0.27 
Crude fibre 0.01 ± 0.003 
Ash 2.87 ± 0.39 
Moisture content 12.75 ± 0.07 
 



































Figure 1. Trypanosome count for intraperitoneal treatment of infected 
rats with honey at 100 mg/Kg body weight of rat at 3 days before 
infection (prophylactic), early (therapeutic) and late stages. Each point 




Prophylactic feeding extended the lifespan for six days 
while early and late stage treatments extended it for 5 
and 3 days, respectively. Parasitaemia was lowered in all 
cases (Figures 1 and 2) when compared with the control. 
 
 
Alkaline phosphatase activities 
 
The results of the activities of ALP in the liver and serum 
of infected rats fed with honey-supplemented diets are 
shown in Table 3. There were significant decreases 
(p<0.05) in liver ALP activities for early and late stage 
treatments in comparison with the infected non-treated 
contrary to the significant increase (p<0.05) observed 
with the prophylactic treatment. There were significant 
increases in serum ALP activities for early and late stage 
treatments whereas the activity was significantly lower 
(p<0.05) with prophylactic treatments. 






























Figure 2. Trypanosome count for infected rats fed with honey 
supplemented diet at 3days before infection (prophylactic), early 





Glutamate pyruvate transaminase activities 
 
Table 4 shows the results of activities of GPT in the liver 
and serum. There were significant increases in the serum 
enzyme activities when compared with the infected but 
not treated rats. Increases were also observed in the liver 
enzyme activities for prophylactic and early stage 




Glutamate oxaloacetate transaminase activities 
 
Results of GOT assay are shown in Table 5. Serum GOT 
activities were significantly higher in rats that received 
early and late stage treatments when compared with the 
activities in the infected but not treated rats. Significant 
increases were also observed in enzyme activities in the 
liver of rats fed with honey-supplemented diet for 





It is well documented that honey has antimicrobial and 




                         Table 3. Specific activities of alkaline phosphatase in the liver and serum of T. brucei-infected rats. 
                        
Enzyme activity (IU/L) Rat groupings 
Liver Serum 
Infected but not treated (Control) 26.92 ± 0.85 366.41 ± 8.05 
Prophylactic honey-treated 43.70 ± 1.18* 325.60 ± 12.52* 
Early stage honey-treated 16.68 ± 0.30* 575.55 ± 7.57* 
Late stage honey-treated 10.22 ± 0.025* 837.12 ± 3.55* 
 
Each value is an average of four determinations ± S.E.M.  
*Values are significantly different when compared with infected but not treated (control) at p<0.05. 
 
 
                    Table 4. Specific activities of glutamate pyruvate transaminase in the liver and serum of T. brucei-infected rats. 
 
Enzyme activity (IU/L) Rat groupings 
Liver Serum 
Infected but not treated 185.30 ± 3.25 2470.40 ± 5.05 
Prophylactic honey-treated 314.77 ± 1.96* 2797.57 ± 0.91* 
Early stage honey- treated 215.40 ± 0.78* 4018.18 ± 6.09* 
Late stage honey-treated 120.33 ± 5.00* 5741.67 ± 5.47* 
 
Each value is an average of four determinations ± S.E.M.  
*Values are significantly different when compared with infected but not treated (control) at p<0.05 
 
 
                   Table 5. Specific activities of glutamate oxaloacetate   transaminase in the liver and serum of T. brucei-infected rats. 
 
Enzyme activity (IU/L) Rat groupings 
Liver Serum 
Infected but not treated 5.86 ± 0.4 421.53 ± 0.31 
Prophylactic honey-treated 122.51 ± 0.66* 679.09 ± 1.85* 
Early stage honey-treated 62.05 ± 0.60* 860.9 ± 6.82* 
Late stage honey-treated 15.61 ± 0.34* 1237.63 ± 2.24* 
 
Each value is an average of four determinations ± S.E.M.  




therapeutic properties (Adebolu, 2005; Okeniyi, 2005; 
Orsolic et al., 2005). We have earlier reported that the 
administration of honey at 3 mg/kg body weight to 
infected rats was able to reduce the parasitaemia and 
extend the life span of rats by 7 days when compared to 
infected non-treated rats (Ekanem and Yusuf, 2005). The 
extended life span in this report for prophylactic, early 
and late stages of honey treated infected rats (Figure 1) 
confirms that honey administered intraperitoneally could 
be a useful and cheap agent in the management of 
African trypanosomosis. The extended life span of 10 
days for prophylactic treatment suggests that routine 
consumption of honey in trypanosomosis endemic 
regions, where administration of toxic and expensive 
drugs is a problem could have some preventive and 
control implications for African trypanosomosis. It is 
perhaps the large carbohydrate content 71.19% (Table 2) 
and possibly in combination with other substances in the 
honey that confers the trypanocidal properties since the 
nature of the carbohydrate content may have implications 
for glucose consumption and the synthesis of the 
essential variable surface glycoprotein required for 
antibody evasion (Smith et al., 2004; Dinglasan et al., 
2005; Roper et al., 2005). 
The attempt to present honey in a simple and 
conducive form in the form of feed to the infected  rats 
also shows that the most effective treatment was the 
prophylactic one (Figure 2) extending the lifespan for six 
days. Even though this is not as effective as 
intraperitoneal administration, it equally suggests that 
routine consumption of honey could have preventive 
implications. 
The activities of enzymes such as ALP, GOT and GPT 
could be important in the diagnosis of diseases as well as 
in the investigation and thorough assessment of feed, 
drugs and extracts used in the treatment as these could 
give indications of progressive toxicity long before the 
actual manifestation of the toxic effects (Hanley et al., 
1986). Damage done to tissues or organs often result in 
increased level of these enzymes in the blood. A specific 
pattern could not be established for these enzyme 
activities in the rat administered with honey-supplemen-
ted diets (Tables 3-5). The general significant increases 





sive damage to organs not necessarily the liver only. It is 
however possible that the observed results were due to 
tissue destruction by the parasites (Pentreath and 
Kennedy, 2004). 
Honey has been useful in curing some diseases 
(Adebolu, 2005; Okeniyi, 2005; Orsolic et al., 2005). We 
have not succeeded in using it to cure African 
trypanosomosis. We however suggest that honey, even 
as part of a regular diet, could be a useful, cheap and 
readily presentable agent in the management of African 
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